493 related articles for article (PubMed ID: 26683615)
21. Hexamethylbisacetamide and disruption of human immunodeficiency virus type 1 latency in CD4(+) T cells.
Choudhary SK; Archin NM; Margolis DM
J Infect Dis; 2008 Apr; 197(8):1162-70. PubMed ID: 18419522
[TBL] [Abstract][Full Text] [Related]
22. p53 represses Sp1 DNA binding and HIV-LTR directed transcription.
Bargonetti J; Chicas A; White D; Prives C
Cell Mol Biol (Noisy-le-grand); 1997 Nov; 43(7):935-49. PubMed ID: 9449526
[TBL] [Abstract][Full Text] [Related]
23. Sp1-dependent activation of a synthetic promoter by human immunodeficiency virus type 1 Tat protein.
Kamine J; Subramanian T; Chinnadurai G
Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8510-4. PubMed ID: 1924310
[TBL] [Abstract][Full Text] [Related]
24. Different members of the Sp1 multigene family exert opposite transcriptional regulation of the long terminal repeat of HIV-1.
Majello B; De Luca P; Hagen G; Suske G; Lania L
Nucleic Acids Res; 1994 Nov; 22(23):4914-21. PubMed ID: 7800480
[TBL] [Abstract][Full Text] [Related]
25. Transcriptional activation of minimal HIV-1 promoter by ORF-1 protein expressed from the SalI-L fragment of human herpesvirus 6.
Kashanchi F; Thompson J; Sadaie MR; Doniger J; Duvall J; Brady JN; Rosenthal LJ
Virology; 1994 May; 201(1):95-106. PubMed ID: 8178493
[TBL] [Abstract][Full Text] [Related]
26. Naf1 Regulates HIV-1 Latency by Suppressing Viral Promoter-Driven Gene Expression in Primary CD4+ T Cells.
Li C; Wang HB; Kuang WD; Ren XX; Song ST; Zhu HZ; Li Q; Xu LR; Guo HJ; Wu L; Wang JH
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795436
[TBL] [Abstract][Full Text] [Related]
27. Role of SP1-binding domains in in vivo transcriptional regulation of the human immunodeficiency virus type 1 long terminal repeat.
Harrich D; Garcia J; Wu F; Mitsuyasu R; Gonazalez J; Gaynor R
J Virol; 1989 Jun; 63(6):2585-91. PubMed ID: 2657100
[TBL] [Abstract][Full Text] [Related]
28. An emerging and variant viral promoter of HIV-1 subtype C exhibits low-level gene expression noise.
Ali H; Bhange D; Mehta K; Gohil Y; Prajapati HK; Byrareddy SN; Buch S; Ranga U
Retrovirology; 2021 Sep; 18(1):27. PubMed ID: 34538278
[TBL] [Abstract][Full Text] [Related]
29. HIV-1 Tat protein can transactivate a heterologous TATAA element independent of viral promoter sequences and the trans-activation response element.
Roebuck KA; Rabbi MF; Kagnoff MF
AIDS; 1997 Feb; 11(2):139-46. PubMed ID: 9030359
[TBL] [Abstract][Full Text] [Related]
30. T-cell activation leads to poor activation of the HIV-1 clade E long terminal repeat and weak association of nuclear factor-kappaB and NFAT with its enhancer region.
Lemieux AM; Paré ME; Audet B; Legault E; Lefort S; Boucher N; Landry S; van Opijnen T; Berkhout B; Naghavi MH; Tremblay MJ; Barbeau B
J Biol Chem; 2004 Dec; 279(51):52949-60. PubMed ID: 15466412
[TBL] [Abstract][Full Text] [Related]
31. Human immunodeficiency viruses containing heterologous enhancer/promoters are replication competent and exhibit different lymphocyte tropisms.
Chang LJ; McNulty E; Martin M
J Virol; 1993 Feb; 67(2):743-52. PubMed ID: 8419644
[TBL] [Abstract][Full Text] [Related]
32. Cellular specificity of HIV-1 replication can be controlled by LTR sequences.
Reed-Inderbitzin E; Maury W
Virology; 2003 Sep; 314(2):680-95. PubMed ID: 14554095
[TBL] [Abstract][Full Text] [Related]
33. NFAT1 enhances HIV-1 gene expression in primary human CD4 T cells.
Cron RQ; Bartz SR; Clausell A; Bort SJ; Klebanoff SJ; Lewis DB
Clin Immunol; 2000 Mar; 94(3):179-91. PubMed ID: 10692237
[TBL] [Abstract][Full Text] [Related]
34. Transcriptional regulation of HIV-1 LTR during antigen-dependent activation of primary T cells by dendritic cells.
Tsunetsugu-Yokota Y; Kato T; Yasuda S; Matsuda Z; Suzuki Y; Koyanagi Y; Yamamoto N; Akagawa K; Cho MW; Takemori T
J Leukoc Biol; 2000 Mar; 67(3):432-40. PubMed ID: 10733105
[TBL] [Abstract][Full Text] [Related]
35. Interplay between viral Tat protein and c-Jun transcription factor in controlling LTR promoter activity in different human immunodeficiency virus type I subtypes.
van der Sluis RM; Derking R; Breidel S; Speijer D; Berkhout B; Jeeninga RE
J Gen Virol; 2014 Apr; 95(Pt 4):968-979. PubMed ID: 24447950
[TBL] [Abstract][Full Text] [Related]
36. SAMHD1 Impairs HIV-1 Gene Expression and Negatively Modulates Reactivation of Viral Latency in CD4
Antonucci JM; Kim SH; St Gelais C; Bonifati S; Li TW; Buzovetsky O; Knecht KM; Duchon AA; Xiong Y; Musier-Forsyth K; Wu L
J Virol; 2018 Aug; 92(15):. PubMed ID: 29793958
[TBL] [Abstract][Full Text] [Related]
37. Variable role of the long terminal repeat Sp1-binding sites in human immunodeficiency virus replication in T lymphocytes.
Parrott C; Seidner T; Duh E; Leonard J; Theodore TS; Buckler-White A; Martin MA; Rabson AB
J Virol; 1991 Mar; 65(3):1414-9. PubMed ID: 1995951
[TBL] [Abstract][Full Text] [Related]
38. Human immunodeficiency virus type 1 long terminal repeat quasispecies differ in basal transcription and nuclear factor recruitment in human glial cells and lymphocytes.
Krebs FC; Mehrens D; Pomeroy S; Goodenow MM; Wigdahl B
J Biomed Sci; 1998; 5(1):31-44. PubMed ID: 9570512
[TBL] [Abstract][Full Text] [Related]
39. ZNF10 inhibits HIV-1 LTR activity through interaction with NF-κB and Sp1 binding motifs.
Nishitsuji H; Sawada L; Sugiyama R; Takaku H
FEBS Lett; 2015 Jul; 589(15):2019-25. PubMed ID: 26096782
[TBL] [Abstract][Full Text] [Related]
40. Differences in transcriptional enhancers of HIV-1 and HIV-2. Response to T cell activation signals.
Tong-Starksen SE; Welsh TM; Peterlin BM
J Immunol; 1990 Dec; 145(12):4348-54. PubMed ID: 2258623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
